arrow
M

Matthew M. Laughon

University of North Carolina
H指数:58
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacokinetics, safety and preliminary efficacy study of montelukast in critically ill infants with developing bronchopulmonary dysplasia (PRISM)

孟鲁司特在发育性支气管肺发育不良危重婴儿中的药代动力学、安全性与初步疗效研究(PRISM)

2026-02-010
OAAI
Comparison of neurodevelopmental outcomes of extremely preterm infants undergoing trans-catheter closure of the patent ductus arteriosus compared to surgical ligation

极低出生体重儿经导管动脉导管未闭封堵术与手术结扎术神经发育结局的比较

2025-09-010
OAAI
Corrigendum to “Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial” J Pediatr. 2025 Apr 28;283:114629

勘误:“Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial” J Pediatr. 2025 Apr 28;283:114629

2025-08-140
PRE
Darbepoetin, Red Cell Mass, and Neuroprotection in Preterm Infants A Randomized Clinical Trial

达泊替泊汀、红细胞质量及神经保护在早产儿中的研究:一项随机临床试验

2025-05-120
PRE
Apnea After 2-Month Vaccinations in Hospitalized Preterm Infants: A Randomized Clinical Trial

住院早产儿在接种2个月疫苗后发生呼吸暂停:一项随机临床试验

2025-01-060
PRE
Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazole
2024-04-031
OA